Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1124-2020Class II

Prometra Programmable 20mL Pump. Catalog No. 91827 The device is an implantable infusion pump. GTIN-14...

Flowonix Medical Inc / initiated 2019-12-24 / Open, Classified / root cause: software

Flowonix Medical Inc began a recall of Prometra Programmable 20mL Pump. Catalog No. 91827 The device is an implantable infusion pump. GTIN-14 00810335020XXX (XXX = in-country language specific) on . FDA classified it as Class II and gives the reason as "A pump alarm function anomaly in the pump firmware code may result in the pump not sending the expected error code notifications to the Programmer, or not emit an audible alarm tone in certain "out of tolerance"...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1124-2020
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Flowonix Medical Inc
Product
Prometra Programmable 20mL Pump. Catalog No. 91827 The device is an implantable infusion pump. GTIN-14 00810335020XXX (XXX = in-country language specific)
Product code
LKK Pump, Infusion, Implanted, Programmable
Reason for recall
A pump alarm function anomaly in the pump firmware code may result in the pump not sending the expected error code notifications to the Programmer, or not emit an audible alarm tone in certain "out of tolerance" conditions associated with the pump's valve system.
Root cause tag
software
FDA root cause
Software change control
Action
***Updated 5/12/2023*** On May 11, 2023, the firm sent an URGENT MEDICAL DEVICE CORRECTION UPDATE letter to all affected customers, which informed them of an update to Flowonix's plan to correct the firmware issue. Flowonix will NOT be conducting an office-based pump firmware update for affected pumps implanted prior to January 2020. Healthcare providers were provided ongoing recommendations for Prometra and Prometra II pumps implanted prior to January 2020, which are impacted by this issue. Healthcare providers should contact their Flowonix Representative or our Technical Solutions Department (1-855-356-9665) in the event cessation of therapy or premature low battery is suspected and/or have general questions regarding this notice. *** On December 24, 2019, the firm notified affected users via an Urgent Medical Device Corrective Action Recall Notice. The firm advised customers of the product issue and reminded customers that the pumps are currently labeled only for use with Infumorph. Due to the low risk that this failure mode may occur, Flowonix is not recommending that pumps be explanted. Healthcare providers were recommended to inform patients regarding the symptoms and adverse health events associated with an unexpected pump stoppage and the appropriate steps to take in the event they suspect a stoppage. The firm will be implementing a correction of firmware errors to bring the pumps back into specification. The firm will follow up when the change has been completed. An office-based pump firmware update is being developed for patients currently implanted with the affected pumps. (Note, as of the 5/12/23 update, implanted pumps will not be receiving a firmware update.)
Quantity in commerce
1083 (OUS)
Distribution
Nationwide domestic distribution. Foreign distribution to United Kingdom, Republic of Ireland, Poland, Greece, Italy, Germany, Netherlands, and Belgium.
Product codes and lots
All units with pump firmware version 0.26 manufactured from 2012 until the present time.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1124-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1120-2020Class IIOngoingVoluntary: Firm initiated
Z-1121-2020Class IIOngoingVoluntary: Firm initiated
Z-1122-2020Class IIOngoingVoluntary: Firm initiated
Z-1123-2020Class IIOngoingVoluntary: Firm initiated
Z-1124-2020Class IIOngoingVoluntary: Firm initiated
Z-1125-2020Class IIOngoingVoluntary: Firm initiated